BD Kiestra Methicillin-resistant Staphylococcus aureus (MRSA) Application, BD Kiestra MRSA App— 510(k) K213280

Substantially Equivalent

Bd Kiestra B.V.

FDA 510(k) clearance K213280 for BD Kiestra Methicillin-resistant Staphylococcus aureus (MRSA) Application, BD Kiestra MRSA App, Substantially Equivalent on 2023-05-04. Applicant: Bd Kiestra B.V..

Clearance details

Applicant: Bd Kiestra B.V.
Product code: Code QQY
Advisory panel: Microbiology
Date received: 2021-10-01
Decision date: 2023-05-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Drachten, NL

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.